Newsroom | 989852 results

MONTRÉAL--(BUSINESS WIRE)--Nouveau Monde Graphite Inc. (“NMG” or the “Company”) (NYSE: NMG, TSX: NOU) announces the payment of accrued interests as part of a previously announced private placement. Settlement of Accrued Interests Upon the approval of the Toronto Stock Exchange and the New York Stock Exchange (the “Exchanges”), the accrued interests owed to Investissement Québec (“Holder”) for the first quarter of 2026 under the unsecured convertible note, as amended and restated, (the “Note”) i...

NEW YORK--(BUSINESS WIRE)--As the first wave of Gen X approaches retirement, many consumers are confronting a difficult transition: after decades focused on growing assets, they now must convert those savings into reliable income, often without the pension safety nets previous generations often relied on. Global Atlantic’s 2026 Retirement Outlook Survey of consumers and financial professionals finds that retirement anxiety extends beyond market swings. Rising health care costs ranked as the top...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Yum! Brands, Inc. (NYSE: YUM) today announced the appointment of Kathleen (Leeny) K. Oberg, former Chief Financial Officer and Executive Vice President, Development of Marriott International, Inc., to its Board of Directors, effective April 1, 2026. “Leeny is a highly accomplished leader with deep global experience and a strong track record of driving disciplined growth,” said Brian Cornell, non-executive chairman of the Yum! Brands Board of Directors. “Her exp...

HOUSTON--(BUSINESS WIRE)--Magnolia Oil & Gas Schedules Conference Call for First Quarter 2026 Results...

BOSTON--(BUSINESS WIRE)--Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced that the first participant has been dosed in the company’s third Phase 1b study of NTX-1955, designed to evaluate its safety and tolerability in generalized anxiety disorder (GAD). NTX-1955 is Newleos’ GABAA-γ1 positive allosteric modulator (PAM) and represents a potential first-in-class treatment for GAD. The Phase 1b study...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceu...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceu...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the first quarter 2026 on April 30, 2026, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m. EDT, April 30, to discuss the company’s financial results for the three-month period that ended March 31, 2026. To access the conference call by phone, use the following conference call registration link and dial-in details will be provided. To acces...

MEMPHIS, Tenn.--(BUSINESS WIRE)--SRM announces the appointment of Jody Guetter as Chief Marketing Officer....

LONDON--(BUSINESS WIRE)--CIBC Innovation Banking announced today that it has provided growth financing for REG Technologies, a leading provider of compliance and regulatory risk software for the insurance and financial services sector. This follows a recent majority investment in REG Technologies by Accel-KKR, a global tech-focused private equity firm. The company will use the financing to accelerate product innovation, build on its commercial capabilities, and expand into new international mar...